Share

Videos

Allergan Spurns Ackman, Valeant's $46 Billion Bid

The Wall Street Journal
|
May 12, 2014 AT 10:38 AM
Allergan formally rejected the $46 billion unsolicited takeover bid made by Valeant Pharmaceuticals, saying the proposal substantially undervalues the Botox maker. Dana Mattioli joins MoneyBeat. Photo: AP.